- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
Decibel Cannabis
Market Cap: CA$72.1m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.13
7D
8.7%
1Y
-3.8%
Impact BioMedical
Market Cap: US$51.8m
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
IBO
US$0.45
7D
-5.1%
1Y
-22.0%
Spectral AI
Market Cap: US$51.5m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$1.60
7D
-2.4%
1Y
-21.2%
Instil Bio
Market Cap: US$51.4m
A biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities.
TIL
US$7.81
7D
6.1%
1Y
-69.6%
Vaso
Market Cap: US$51.0m
Operates in the healthcare equipment and information technology industries in the United States and internationally.
VASO
US$0.29
7D
5.5%
1Y
133.0%
QTREX Quantum
Market Cap: US$51.0m
Engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA.
QTEX
US$0.87
7D
-7.8%
1Y
-24.0%
SCYNEXIS
Market Cap: US$50.7m
A biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States.
SCYX
US$5.26
7D
3.3%
1Y
-22.2%
Precision Optics Corporation
Market Cap: US$49.9m
Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
POCI
US$4.44
7D
6.1%
1Y
-8.6%
Nuo Therapeutics
Market Cap: US$49.9m
Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.
AURX
US$1.07
7D
7.0%
1Y
-32.6%
CapForce
Market Cap: US$49.5m
Operates as a capital markets advisory and financial technology company.
CFOR
US$4.01
7D
0.4%
1Y
4,013,900.0%
Hyperion DeFi
Market Cap: US$49.4m
A DeFi company, engages in building on Hyperliquid.
HYPD
US$3.26
7D
14.8%
1Y
-46.6%
aTyr Pharma
Market Cap: US$49.2m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$0.53
7D
2.1%
1Y
-89.7%
Veraxa Biotech
Market Cap: US$49.2m
Develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment.
VRXA
US$1.78
7D
-4.3%
1Y
-82.9%
Baird Medical Investment Holdings
Market Cap: US$49.0m
Engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.
BDMD
US$1.16
7D
1.8%
1Y
-51.5%
TransCode Therapeutics
Market Cap: US$48.6m
A clinical-stage company, develops immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers.
RNAZ
US$2.70
7D
-14.6%
1Y
-72.4%
BioScience Health Innovations
Market Cap: US$48.3m
Operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States.
BHIC
US$4.06
7D
-37.2%
1Y
n/a
Vicapsys Life Sciences
Market Cap: US$46.9m
Focuses on the development and commercialization of VICAPSYN, a proprietary product.
VICP
US$1.45
7D
0%
1Y
n/a
Nasus Pharma
Market Cap: US$46.8m
A clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions.
NSRX
US$4.07
7D
10.0%
1Y
-49.1%
Metagenomi Therapeutics
Market Cap: US$46.5m
An in vivo genome editing company, develops curative genetic medicines in the United States.
MGX
US$1.21
7D
-0.8%
1Y
-35.6%
Filana Therapeutics
Market Cap: US$46.4m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
FLNA
US$0.93
7D
4.5%
1Y
-56.9%
Mereo BioPharma Group
Market Cap: US$46.4m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States.
MREO
US$0.29
7D
-5.9%
1Y
-83.4%
Grace Therapeutics
Market Cap: US$46.3m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.18
7D
0.9%
1Y
-32.9%
Mach7 Technologies
Market Cap: AU$64.6m
Develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally.
M7T
AU$0.28
7D
0%
1Y
-16.2%
Context Therapeutics
Market Cap: US$45.9m
A clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.47
7D
-12.2%
1Y
-46.7%
Covalon Technologies
Market Cap: CA$63.5m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
COV
CA$2.31
7D
-1.7%
1Y
-4.9%
NetraMark Holdings
Market Cap: CA$63.4m
Provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide.
AIAI
CA$0.67
7D
-2.9%
1Y
-61.3%
Xtant Medical Holdings
Market Cap: US$45.6m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.32
7D
-2.6%
1Y
-49.2%
Cyclopharm
Market Cap: AU$63.7m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
CYC
AU$0.51
7D
2.0%
1Y
-49.3%
Entropy Neurodynamics
Market Cap: AU$63.6m
A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.
ENP
AU$0.039
7D
5.4%
1Y
18.2%
Seres Therapeutics
Market Cap: US$45.3m
A clinical-stage company, focuses on developing biotherapeutics for serious diseases.
MCRB
US$4.66
7D
3.3%
1Y
-75.8%
Rocket Doctor AI
Market Cap: CA$62.5m
Provides personalized health care information services in Canada and United States.
AIDR
CA$0.62
7D
5.1%
1Y
-16.2%
Cyberfuels Holding
Market Cap: US$45.0m
Provides sustainable energy solutions.
CBRF
US$0.36
7D
-8.8%
1Y
-40.7%
Veru
Market Cap: US$45.0m
A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally.
VERU
US$2.59
7D
-1.5%
1Y
-25.8%
Karyopharm Therapeutics
Market Cap: US$44.5m
A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.
KPTI
US$1.86
7D
2.8%
1Y
-70.5%
Tevogen
Market Cap: US$44.0m
A clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$6.81
7D
3.5%
1Y
-85.2%
Cryosite
Market Cap: AU$61.0m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$1.25
7D
0%
1Y
56.3%